Efficacy and Safety of the PD-1 Inhibitor Combined with Albumin-Bound Paclitaxel and Nedaplatin in Preoperative Neoadjuvant Therapy of Unresectable Stage III Lung Squamous Cell Carcinoma

AIM: To investigate the efficacy and safety of preoperative neoadjuvant therapy (PD-1 inhibitor plus nab-PTX and nedaplatin) for resectable stage III lung squamous cell carcinoma (SCC) patients. METHODS: Patients with locally advanced lung SCC (stage IIIA, IIIB) who received PD-1 inhibitor combined...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hongyan, Wang, Wenjing, Yin, Junlei, Song, Chengcun, Li, Lin, Sun, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760041/
https://www.ncbi.nlm.nih.gov/pubmed/36540715
http://dx.doi.org/10.2147/DDDT.S388777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760041/
https://www.ncbi.nlm.nih.gov/pubmed/36540715
http://dx.doi.org/10.2147/DDDT.S388777

Ejemplares similares